"Genetic Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions.
| Descriptor ID |
D015316
|
| MeSH Number(s) |
E02.095.301 E05.393.420.301
|
| Concept/Terms |
Genetic Therapy- Genetic Therapy
- Genetic Therapies
- Therapies, Genetic
- Therapy, Genetic
- Therapy, DNA
- DNA Therapy
Genetic Therapy, Somatic- Genetic Therapy, Somatic
- Genetic Therapies, Somatic
- Somatic Genetic Therapies
- Somatic Genetic Therapy
- Therapies, Somatic Genetic
- Therapy, Somatic Genetic
Genetic Therapy, Gametic- Genetic Therapy, Gametic
- Gametic Genetic Therapies
- Gametic Genetic Therapy
- Genetic Therapies, Gametic
- Therapies, Gametic Genetic
- Therapy, Gametic Genetic
|
Below are MeSH descriptors whose meaning is more general than "Genetic Therapy".
Below are MeSH descriptors whose meaning is more specific than "Genetic Therapy".
This graph shows the total number of publications written about "Genetic Therapy" by people in this website by year, and whether "Genetic Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 11 | 5 | 16 |
| 1997 | 7 | 2 | 9 |
| 1998 | 14 | 2 | 16 |
| 1999 | 21 | 1 | 22 |
| 2000 | 14 | 11 | 25 |
| 2001 | 13 | 1 | 14 |
| 2002 | 19 | 12 | 31 |
| 2003 | 11 | 5 | 16 |
| 2004 | 19 | 4 | 23 |
| 2005 | 19 | 3 | 22 |
| 2006 | 8 | 5 | 13 |
| 2007 | 12 | 5 | 17 |
| 2008 | 4 | 5 | 9 |
| 2009 | 6 | 3 | 9 |
| 2010 | 6 | 7 | 13 |
| 2011 | 15 | 4 | 19 |
| 2012 | 13 | 3 | 16 |
| 2013 | 10 | 3 | 13 |
| 2014 | 7 | 7 | 14 |
| 2015 | 10 | 5 | 15 |
| 2016 | 11 | 6 | 17 |
| 2017 | 7 | 7 | 14 |
| 2018 | 8 | 4 | 12 |
| 2019 | 7 | 7 | 14 |
| 2020 | 5 | 4 | 9 |
| 2021 | 5 | 7 | 12 |
| 2022 | 1 | 7 | 8 |
| 2023 | 0 | 10 | 10 |
| 2024 | 7 | 5 | 12 |
| 2025 | 14 | 4 | 18 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genetic Therapy" by people in Profiles.
-
Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L-Amino Acid Decarboxylase Deficiency Using an MR-Compatible Cannula: 48 Weeks of Follow-Up. J Inherit Metab Dis. 2026 Mar; 49(2):e70151.
-
Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors. Nat Commun. 2025 Dec 09; 16(1):10987.
-
Gene Therapy for Inherited Cardiac Arrhythmias. J Cardiovasc Transl Res. 2025 Dec; 18(6):1525-1539.
-
Safety and Feasibility of Fertility Preservation and Fertility Outcomes in Patients with Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia Undergoing Gene Therapy. Transplant Cell Ther. 2025 Nov; 31(11):934.e1-934.e8.
-
Unexpected Seizure Complication Post-Apheresis in a Young Adult With Sickle Cell Disease: A Case Report. J Clin Apher. 2025 Aug; 40(4):e70044.
-
Elevated Troponin in an Infant With Spinal Muscular Atrophy. J Child Neurol. 2026 Jan; 41(1):105-108.
-
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series. BMC Neurol. 2025 Jul 07; 25(1):283.
-
Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases. Prog Retin Eye Res. 2025 Jul; 107:101376.
-
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease. N Engl J Med. 2025 Jun 12; 392(22):2235-2243.
-
CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 2025 Jul; 108(1):145-149.